|
|
|
Profit & Loss |
|
|
2023/12 - Final RMB(¥) | %Chg (Final to Final) | 2022/12 RMB(¥) | 2021/12 RMB(¥) |
Turnover | 363,826,000 | -3.256% | 376,070,000 | 494,280,000 | Cost of Sales | -- | -- | -- | -- | Gross Profit | -- | -- | -- | -- | Change in FV & Impairment on Inv. Prop. | 1,270,000 | -96.538% | 36,689,000 | -- | Change in FV & Impairment on Others | (35,747,000) | 18.509% | (30,164,000) | (72,000,000) | Profit / (Loss) on Disposal | -- | -- | -- | -- | Other Non-operating Items | -- | -- | -- | -- | Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | Profit / (Loss) before Taxation | (463,552,000) | 22.311% | (378,994,000) | (358,862,000) | Taxation | 3,409,000 | 6332.075% | 53,000 | (22,581,000) | Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | Non-controlling Interests | 6,893,000 | -59.934% | 17,204,000 | 13,476,000 | Others | -- | -- | -- | -- | Profit / (Loss) Attributable to Shareholders | (453,250,000) | 25.298% | (361,737,000) | (367,967,000) | Net Finance Costs / (Income) | 229,712,000 | 13.860% | 201,750,000 | 164,421,000 | Depreciation & Amortisation | 197,407,000 | 29.936% | 151,926,000 | 156,145,000 | Directors' Emoluments | -- | -- | 5,850,000 | 5,415,000 | Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | | Market Valuation Indicators | EPS (cts) | -38.900 | -% | -15.500 | -15.800 | DPS (cts) | 0.000 | -- | 0.000 | 0.000 | Dividend Payout Ratio (%) | -- | -- | -- | -- | Cash flow per share ($) | -- | -- | -0.041 | -0.221 | NBV per share ($) | 0.804 | -% | 1.284 | 1.528 |
|
|
|
|
|
|